Experience

Après-demain SA

• Switzerland
• Investment Management
• 1 - 100 Employee

• Président

  • Jan 2017 - Present

  Après-demain SA is the parent company of the Group that consists of a Life Sciences Division (Debiopharm) and an Asset Management division.



Debiopharm

• Switzerland
• Pharmaceutical Manufacturing
• 300 - 400 Employee

• President & Delegate of the Board, Debiopharm Group

  • Jan 2017 - Present

• Co-President & Delegate of the Board, Debiopharm Group

  • Jan 2006 - Jan 2017

  Directly in charge of all the Debiopharm Group's companies, their strategies and asset managements: - 2006: Creation of Après-demain SA (Debiopharm Investment), the asset management division of the Group. It was founded to ensure our financial and strategic independence. The main activities of Après-demain SA cover 6 areas: Direct Private Equity, Private Equity Funds, Long-term Participation, Help & Personal Care, Finance and Real Estate.- 2008: Creation of Debiopharm Innovation Fund, the strategic investment fund of Debiopharm. The company invests in Smart Data and Digital Health to have a more comprehensive impact on the patient journey.

• Executive Vice President at Debiopharm International SA

  • May 2001 - Jan 2006



Innovation Scientifique Dermatologique I.S.D

• France
• Personal Care Product Manufacturing

• CEO

  • Sep 1998 - Apr 2001

• CEO & President

  • Sep 1976 - Sep 1998